Evidence map›Paper›PMID 40253441›Full record

ArticleScientific reports2025

A quantum crystallographic protocol for general use.

Yaser Balmohammadi, Lorraine A Malaspina, Yuiga Nakamura, Georgia Cametti, Milosz Siczek, Simon Grabowsky

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Periodic Hirshfeld Atom Refinement.The journal of physical chemistry letters · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yaser BalmohammadiDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012, Bern, Switzerland.
Lorraine A MalaspinaDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012, Bern, Switzerland.
Yuiga NakamuraJapan Synchrotron Radiation Research Institute (JASRI), Sayo-cho, Hyogo, 679-5198, Japan.
Georgia CamettiInstitute of Geological Sciences, University of Bern, Baltzerstrasse 3, 3012, Bern, Switzerland.
Milosz SiczekFaculty of Chemistry, University of Wrocław, F. Joliot-Curie 14, 50383, Wrocław, Poland.
Simon GrabowskyDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012, Bern, Switzerland. simon.grabowsky@unibe.ch.

Funding

Swiss National Science Foundation 206021_177033
6 · The paper itself

Abstract

Quantum crystallography has become ever more important in recent years for the accurate determination of molecular and crystal structures. The results of quantum crystallographic refinements of X-ray data are as accurate and precise as from neutron diffraction and they give access to the complete electronic structure of the compound under investigation. Is the method now mature enough and easy enough to use to extend and ultimately supersede standard X-ray crystal structure determination routines? We utilize the world's most common crystal structure-the YLID test crystal that every owner of an X-ray diffractometer receives with their machine-to show under which circumstances routine, low-resolution, and even room-temperature measurements can be subjected to quantum crystallographic refinement. Based on this, we describe a quantum crystallographic protocol step by step that makes application of quantum crystallographic refinement easy to use and reproducible. We encourage that valuable YLID test measurements are not discarded but made available for method development, increasing the availability of repeated measurements from a handful to tens of thousands.

Identifiers

PMID40253441
PMCPMC12009286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.